 | • レポートコード：MRC2-11QY03277 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、150ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はバイオプロテイン医薬品のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、治療用タンパク質、ワクチン）市場規模、用途別（製薬・バイオテクノロジー企業、CRO、学術）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別バイオプロテイン医薬品の競争状況、市場シェア ・世界のバイオプロテイン医薬品市場：種類別市場規模 2015年-2020年（モノクローナル抗体、治療用タンパク質、ワクチン） ・世界のバイオプロテイン医薬品市場：種類別市場規模予測 2021年-2026年（モノクローナル抗体、治療用タンパク質、ワクチン） ・世界のバイオプロテイン医薬品市場：用途別市場規模 2015年-2020年（製薬・バイオテクノロジー企業、CRO、学術） ・世界のバイオプロテイン医薬品市場：用途別市場規模予測 2021年-2026年（製薬・バイオテクノロジー企業、CRO、学術） ・北米のバイオプロテイン医薬品市場分析：米国、カナダ ・ヨーロッパのバイオプロテイン医薬品市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのバイオプロテイン医薬品市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のバイオプロテイン医薬品市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのバイオプロテイン医薬品市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Bayer AG、Eli Lilly and Company、Amgen Inc.、Biocon Ltd.、Dr. Reddy’s Laboratories、Roche、Fresenius kabi、GlaxoSmithKline、Johnson & Johnson、Merck、Novartis AG、Panacea Biotec、ProBioGen AG、Sanofi、Reliance Life Science Pvt. Ltd. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Bio-protein Drug Market
The global Bio-protein Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Bio-protein Drug Scope and Market Size
Bio-protein Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bio-protein Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Bio-protein Drug market is segmented into
Monoclonal Antibodies
Therapeutic Proteins
Vaccines
Segment by Application, the Bio-protein Drug market is segmented into
Pharma and Biotech Companies
CROs
Academics
Regional and Country-level Analysis
The Bio-protein Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Bio-protein Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bio-protein Drug Market Share Analysis
Bio-protein Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bio-protein Drug business, the date to enter into the Bio-protein Drug market, Bio-protein Drug product introduction, recent developments, etc.
The major vendors covered:
Abbott Laboratories
Bayer AG
Eli Lilly and Company
Amgen Inc.
Biocon Ltd.
Dr. Reddy’s Laboratories
Roche
Fresenius kabi
GlaxoSmithKline
Johnson & Johnson
Merck
Novartis AG
Panacea Biotec
ProBioGen AG
Sanofi
Reliance Life Science Pvt. Ltd.
1 Study Coverage
1.1 Bio-protein Drug Product Introduction
1.2 Market Segments
1.3 Key Bio-protein Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Bio-protein Drug Market Size Growth Rate by Type
1.4.2 Monoclonal Antibodies
1.4.3 Therapeutic Proteins
1.4.4 Vaccines
1.5 Market by Application
1.5.1 Global Bio-protein Drug Market Size Growth Rate by Application
1.5.2 Pharma and Biotech Companies
1.5.3 CROs
1.5.4 Academics
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Bio-protein Drug Market Size, Estimates and Forecasts
2.1.1 Global Bio-protein Drug Revenue 2015-2026
2.1.2 Global Bio-protein Drug Sales 2015-2026
2.2 Global Bio-protein Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Bio-protein Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Bio-protein Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Bio-protein Drug Competitor Landscape by Players
3.1 Bio-protein Drug Sales by Manufacturers
3.1.1 Bio-protein Drug Sales by Manufacturers (2015-2020)
3.1.2 Bio-protein Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Bio-protein Drug Revenue by Manufacturers
3.2.1 Bio-protein Drug Revenue by Manufacturers (2015-2020)
3.2.2 Bio-protein Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Bio-protein Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Bio-protein Drug Revenue in 2019
3.2.5 Global Bio-protein Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Bio-protein Drug Price by Manufacturers
3.4 Bio-protein Drug Manufacturing Base Distribution, Product Types
3.4.1 Bio-protein Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bio-protein Drug Product Type
3.4.3 Date of International Manufacturers Enter into Bio-protein Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bio-protein Drug Market Size by Type (2015-2020)
4.1.1 Global Bio-protein Drug Sales by Type (2015-2020)
4.1.2 Global Bio-protein Drug Revenue by Type (2015-2020)
4.1.3 Bio-protein Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Bio-protein Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Bio-protein Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Bio-protein Drug Revenue Forecast by Type (2021-2026)
4.2.3 Bio-protein Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Bio-protein Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Bio-protein Drug Market Size by Application (2015-2020)
5.1.1 Global Bio-protein Drug Sales by Application (2015-2020)
5.1.2 Global Bio-protein Drug Revenue by Application (2015-2020)
5.1.3 Bio-protein Drug Price by Application (2015-2020)
5.2 Bio-protein Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Bio-protein Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Bio-protein Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Bio-protein Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Bio-protein Drug by Country
6.1.1 North America Bio-protein Drug Sales by Country
6.1.2 North America Bio-protein Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Bio-protein Drug Market Facts & Figures by Type
6.3 North America Bio-protein Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Bio-protein Drug by Country
7.1.1 Europe Bio-protein Drug Sales by Country
7.1.2 Europe Bio-protein Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bio-protein Drug Market Facts & Figures by Type
7.3 Europe Bio-protein Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Bio-protein Drug by Region
8.1.1 Asia Pacific Bio-protein Drug Sales by Region
8.1.2 Asia Pacific Bio-protein Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Bio-protein Drug Market Facts & Figures by Type
8.3 Asia Pacific Bio-protein Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Bio-protein Drug by Country
9.1.1 Latin America Bio-protein Drug Sales by Country
9.1.2 Latin America Bio-protein Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Bio-protein Drug Market Facts & Figures by Type
9.3 Central & South America Bio-protein Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Bio-protein Drug by Country
10.1.1 Middle East and Africa Bio-protein Drug Sales by Country
10.1.2 Middle East and Africa Bio-protein Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Bio-protein Drug Market Facts & Figures by Type
10.3 Middle East and Africa Bio-protein Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Description and Business Overview
11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Laboratories Bio-protein Drug Products Offered
11.1.5 Abbott Laboratories Related Developments
11.2 Bayer AG
11.2.1 Bayer AG Corporation Information
11.2.2 Bayer AG Description and Business Overview
11.2.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bayer AG Bio-protein Drug Products Offered
11.2.5 Bayer AG Related Developments
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Corporation Information
11.3.2 Eli Lilly and Company Description and Business Overview
11.3.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly and Company Bio-protein Drug Products Offered
11.3.5 Eli Lilly and Company Related Developments
11.4 Amgen Inc.
11.4.1 Amgen Inc. Corporation Information
11.4.2 Amgen Inc. Description and Business Overview
11.4.3 Amgen Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Amgen Inc. Bio-protein Drug Products Offered
11.4.5 Amgen Inc. Related Developments
11.5 Biocon Ltd.
11.5.1 Biocon Ltd. Corporation Information
11.5.2 Biocon Ltd. Description and Business Overview
11.5.3 Biocon Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Biocon Ltd. Bio-protein Drug Products Offered
11.5.5 Biocon Ltd. Related Developments
11.6 Dr. Reddy’s Laboratories
11.6.1 Dr. Reddy’s Laboratories Corporation Information
11.6.2 Dr. Reddy’s Laboratories Description and Business Overview
11.6.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Dr. Reddy’s Laboratories Bio-protein Drug Products Offered
11.6.5 Dr. Reddy’s Laboratories Related Developments
11.7 Roche
11.7.1 Roche Corporation Information
11.7.2 Roche Description and Business Overview
11.7.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Roche Bio-protein Drug Products Offered
11.7.5 Roche Related Developments
11.8 Fresenius kabi
11.8.1 Fresenius kabi Corporation Information
11.8.2 Fresenius kabi Description and Business Overview
11.8.3 Fresenius kabi Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Fresenius kabi Bio-protein Drug Products Offered
11.8.5 Fresenius kabi Related Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Corporation Information
11.9.2 GlaxoSmithKline Description and Business Overview
11.9.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.9.4 GlaxoSmithKline Bio-protein Drug Products Offered
11.9.5 GlaxoSmithKline Related Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Corporation Information
11.10.2 Johnson & Johnson Description and Business Overview
11.10.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Johnson & Johnson Bio-protein Drug Products Offered
11.10.5 Johnson & Johnson Related Developments
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Description and Business Overview
11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Laboratories Bio-protein Drug Products Offered
11.1.5 Abbott Laboratories Related Developments
11.12 Novartis AG
11.12.1 Novartis AG Corporation Information
11.12.2 Novartis AG Description and Business Overview
11.12.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Novartis AG Products Offered
11.12.5 Novartis AG Related Developments
11.13 Panacea Biotec
11.13.1 Panacea Biotec Corporation Information
11.13.2 Panacea Biotec Description and Business Overview
11.13.3 Panacea Biotec Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Panacea Biotec Products Offered
11.13.5 Panacea Biotec Related Developments
11.14 ProBioGen AG
11.14.1 ProBioGen AG Corporation Information
11.14.2 ProBioGen AG Description and Business Overview
11.14.3 ProBioGen AG Sales, Revenue and Gross Margin (2015-2020)
11.14.4 ProBioGen AG Products Offered
11.14.5 ProBioGen AG Related Developments
11.15 Sanofi
11.15.1 Sanofi Corporation Information
11.15.2 Sanofi Description and Business Overview
11.15.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Sanofi Products Offered
11.15.5 Sanofi Related Developments
11.16 Reliance Life Science Pvt. Ltd.
11.16.1 Reliance Life Science Pvt. Ltd. Corporation Information
11.16.2 Reliance Life Science Pvt. Ltd. Description and Business Overview
11.16.3 Reliance Life Science Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Reliance Life Science Pvt. Ltd. Products Offered
11.16.5 Reliance Life Science Pvt. Ltd. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Bio-protein Drug Market Estimates and Projections by Region
12.1.1 Global Bio-protein Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Bio-protein Drug Revenue Forecast by Regions 2021-2026
12.2 North America Bio-protein Drug Market Size Forecast (2021-2026)
12.2.1 North America: Bio-protein Drug Sales Forecast (2021-2026)
12.2.2 North America: Bio-protein Drug Revenue Forecast (2021-2026)
12.2.3 North America: Bio-protein Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Bio-protein Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Bio-protein Drug Sales Forecast (2021-2026)
12.3.2 Europe: Bio-protein Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Bio-protein Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Bio-protein Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Bio-protein Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Bio-protein Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Bio-protein Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Bio-protein Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Bio-protein Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Bio-protein Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Bio-protein Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Bio-protein Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Bio-protein Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Bio-protein Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Bio-protein Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Bio-protein Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bio-protein Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Bio-protein Drug Market Segments
Table 2. Ranking of Global Top Bio-protein Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Bio-protein Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Monoclonal Antibodies
Table 5. Major Manufacturers of Therapeutic Proteins
Table 6. Major Manufacturers of Vaccines
Table 7. Global Bio-protein Drug Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Bio-protein Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Bio-protein Drug Sales by Regions 2015-2020 (K Units)
Table 10. Global Bio-protein Drug Sales Market Share by Regions (2015-2020)
Table 11. Global Bio-protein Drug Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Bio-protein Drug Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Bio-protein Drug Sales Share by Manufacturers (2015-2020)
Table 14. Global Bio-protein Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Bio-protein Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio-protein Drug as of 2019)
Table 16. Bio-protein Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Bio-protein Drug Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Bio-protein Drug Price (2015-2020) (USD/Unit)
Table 19. Bio-protein Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Bio-protein Drug Product Type
Table 21. Date of International Manufacturers Enter into Bio-protein Drug Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Bio-protein Drug Sales by Type (2015-2020) (K Units)
Table 24. Global Bio-protein Drug Sales Share by Type (2015-2020)
Table 25. Global Bio-protein Drug Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Bio-protein Drug Revenue Share by Type (2015-2020)
Table 27. Bio-protein Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Bio-protein Drug Sales by Application (2015-2020) (K Units)
Table 29. Global Bio-protein Drug Sales Share by Application (2015-2020)
Table 30. North America Bio-protein Drug Sales by Country (2015-2020) (K Units)
Table 31. North America Bio-protein Drug Sales Market Share by Country (2015-2020)
Table 32. North America Bio-protein Drug Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Bio-protein Drug Revenue Market Share by Country (2015-2020)
Table 34. North America Bio-protein Drug Sales by Type (2015-2020) (K Units)
Table 35. North America Bio-protein Drug Sales Market Share by Type (2015-2020)
Table 36. North America Bio-protein Drug Sales by Application (2015-2020) (K Units)
Table 37. North America Bio-protein Drug Sales Market Share by Application (2015-2020)
Table 38. Europe Bio-protein Drug Sales by Country (2015-2020) (K Units)
Table 39. Europe Bio-protein Drug Sales Market Share by Country (2015-2020)
Table 40. Europe Bio-protein Drug Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Bio-protein Drug Revenue Market Share by Country (2015-2020)
Table 42. Europe Bio-protein Drug Sales by Type (2015-2020) (K Units)
Table 43. Europe Bio-protein Drug Sales Market Share by Type (2015-2020)
Table 44. Europe Bio-protein Drug Sales by Application (2015-2020) (K Units)
Table 45. Europe Bio-protein Drug Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Bio-protein Drug Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Bio-protein Drug Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Bio-protein Drug Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Bio-protein Drug Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Bio-protein Drug Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Bio-protein Drug Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Bio-protein Drug Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Bio-protein Drug Sales Market Share by Application (2015-2020)
Table 54. Latin America Bio-protein Drug Sales by Country (2015-2020) (K Units)
Table 55. Latin America Bio-protein Drug Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Bio-protein Drug Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Bio-protein Drug Revenue Market Share by Country (2015-2020)
Table 58. Latin America Bio-protein Drug Sales by Type (2015-2020) (K Units)
Table 59. Latin America Bio-protein Drug Sales Market Share by Type (2015-2020)
Table 60. Latin America Bio-protein Drug Sales by Application (2015-2020) (K Units)
Table 61. Latin America Bio-protein Drug Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Bio-protein Drug Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Bio-protein Drug Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Bio-protein Drug Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Bio-protein Drug Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Bio-protein Drug Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Bio-protein Drug Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Bio-protein Drug Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Bio-protein Drug Sales Market Share by Application (2015-2020)
Table 70. Abbott Laboratories Corporation Information
Table 71. Abbott Laboratories Description and Major Businesses
Table 72. Abbott Laboratories Bio-protein Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Abbott Laboratories Product
Table 74. Abbott Laboratories Recent Development
Table 75. Bayer AG Corporation Information
Table 76. Bayer AG Description and Major Businesses
Table 77. Bayer AG Bio-protein Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Bayer AG Product
Table 79. Bayer AG Recent Development
Table 80. Eli Lilly and Company Corporation Information
Table 81. Eli Lilly and Company Description and Major Businesses
Table 82. Eli Lilly and Company Bio-protein Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Eli Lilly and Company Product
Table 84. Eli Lilly and Company Recent Development
Table 85. Amgen Inc. Corporation Information
Table 86. Amgen Inc. Description and Major Businesses
Table 87. Amgen Inc. Bio-protein Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Amgen Inc. Product
Table 89. Amgen Inc. Recent Development
Table 90. Biocon Ltd. Corporation Information
Table 91. Biocon Ltd. Description and Major Businesses
Table 92. Biocon Ltd. Bio-protein Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Biocon Ltd. Product
Table 94. Biocon Ltd. Recent Development
Table 95. Dr. Reddy’s Laboratories Corporation Information
Table 96. Dr. Reddy’s Laboratories Description and Major Businesses
Table 97. Dr. Reddy’s Laboratories Bio-protein Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Dr. Reddy’s Laboratories Product
Table 99. Dr. Reddy’s Laboratories Recent Development
Table 100. Roche Corporation Information
Table 101. Roche Description and Major Businesses
Table 102. Roche Bio-protein Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Roche Product
Table 104. Roche Recent Development
Table 105. Fresenius kabi Corporation Information
Table 106. Fresenius kabi Description and Major Businesses
Table 107. Fresenius kabi Bio-protein Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Fresenius kabi Product
Table 109. Fresenius kabi Recent Development
Table 110. GlaxoSmithKline Corporation Information
Table 111. GlaxoSmithKline Description and Major Businesses
Table 112. GlaxoSmithKline Bio-protein Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. GlaxoSmithKline Product
Table 114. GlaxoSmithKline Recent Development
Table 115. Johnson & Johnson Corporation Information
Table 116. Johnson & Johnson Description and Major Businesses
Table 117. Johnson & Johnson Bio-protein Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Johnson & Johnson Product
Table 119. Johnson & Johnson Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Major Businesses
Table 122. Merck Bio-protein Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Merck Product
Table 124. Merck Recent Development
Table 125. Novartis AG Corporation Information
Table 126. Novartis AG Description and Major Businesses
Table 127. Novartis AG Bio-protein Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Novartis AG Product
Table 129. Novartis AG Recent Development
Table 130. Panacea Biotec Corporation Information
Table 131. Panacea Biotec Description and Major Businesses
Table 132. Panacea Biotec Bio-protein Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Panacea Biotec Product
Table 134. Panacea Biotec Recent Development
Table 135. ProBioGen AG Corporation Information
Table 136. ProBioGen AG Description and Major Businesses
Table 137. ProBioGen AG Bio-protein Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. ProBioGen AG Product
Table 139. ProBioGen AG Recent Development
Table 140. Sanofi Corporation Information
Table 141. Sanofi Description and Major Businesses
Table 142. Sanofi Bio-protein Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Sanofi Product
Table 144. Sanofi Recent Development
Table 145. Reliance Life Science Pvt. Ltd. Corporation Information
Table 146. Reliance Life Science Pvt. Ltd. Description and Major Businesses
Table 147. Reliance Life Science Pvt. Ltd. Bio-protein Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Reliance Life Science Pvt. Ltd. Product
Table 149. Reliance Life Science Pvt. Ltd. Recent Development
Table 150. Global Bio-protein Drug Sales Forecast by Regions (2021-2026) (K Units)
Table 151. Global Bio-protein Drug Sales Market Share Forecast by Regions (2021-2026)
Table 152. Global Bio-protein Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 153. Global Bio-protein Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 154. North America: Bio-protein Drug Sales Forecast by Country (2021-2026) (K Units)
Table 155. North America: Bio-protein Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Europe: Bio-protein Drug Sales Forecast by Country (2021-2026) (K Units)
Table 157. Europe: Bio-protein Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Asia Pacific: Bio-protein Drug Sales Forecast by Region (2021-2026) (K Units)
Table 159. Asia Pacific: Bio-protein Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 160. Latin America: Bio-protein Drug Sales Forecast by Country (2021-2026) (K Units)
Table 161. Latin America: Bio-protein Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Middle East and Africa: Bio-protein Drug Sales Forecast by Country (2021-2026) (K Units)
Table 163. Middle East and Africa: Bio-protein Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 165. Key Challenges
Table 166. Market Risks
Table 167. Main Points Interviewed from Key Bio-protein Drug Players
Table 168. Bio-protein Drug Customers List
Table 169. Bio-protein Drug Distributors List
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio-protein Drug Product Picture
Figure 2. Global Bio-protein Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Monoclonal Antibodies Product Picture
Figure 4. Therapeutic Proteins Product Picture
Figure 5. Vaccines Product Picture
Figure 6. Global Bio-protein Drug Sales Market Share by Application in 2020 & 2026
Figure 7. Pharma and Biotech Companies
Figure 8. CROs
Figure 9. Academics
Figure 10. Bio-protein Drug Report Years Considered
Figure 11. Global Bio-protein Drug Market Size 2015-2026 (US$ Million)
Figure 12. Global Bio-protein Drug Sales 2015-2026 (K Units)
Figure 13. Global Bio-protein Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Bio-protein Drug Sales Market Share by Region (2015-2020)
Figure 15. Global Bio-protein Drug Sales Market Share by Region in 2019
Figure 16. Global Bio-protein Drug Revenue Market Share by Region (2015-2020)
Figure 17. Global Bio-protein Drug Revenue Market Share by Region in 2019
Figure 18. Global Bio-protein Drug Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Bio-protein Drug Revenue in 2019
Figure 20. Bio-protein Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Bio-protein Drug Sales Market Share by Type (2015-2020)
Figure 22. Global Bio-protein Drug Sales Market Share by Type in 2019
Figure 23. Global Bio-protein Drug Revenue Market Share by Type (2015-2020)
Figure 24. Global Bio-protein Drug Revenue Market Share by Type in 2019
Figure 25. Global Bio-protein Drug Market Share by Price Range (2015-2020)
Figure 26. Global Bio-protein Drug Sales Market Share by Application (2015-2020)
Figure 27. Global Bio-protein Drug Sales Market Share by Application in 2019
Figure 28. Global Bio-protein Drug Revenue Market Share by Application (2015-2020)
Figure 29. Global Bio-protein Drug Revenue Market Share by Application in 2019
Figure 30. North America Bio-protein Drug Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Bio-protein Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Bio-protein Drug Sales Market Share by Country in 2019
Figure 33. North America Bio-protein Drug Revenue Market Share by Country in 2019
Figure 34. U.S. Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Bio-protein Drug Market Share by Type in 2019
Figure 39. North America Bio-protein Drug Market Share by Application in 2019
Figure 40. Europe Bio-protein Drug Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Bio-protein Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Bio-protein Drug Sales Market Share by Country in 2019
Figure 43. Europe Bio-protein Drug Revenue Market Share by Country in 2019
Figure 44. Germany Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Bio-protein Drug Market Share by Type in 2019
Figure 55. Europe Bio-protein Drug Market Share by Application in 2019
Figure 56. Asia Pacific Bio-protein Drug Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Bio-protein Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Bio-protein Drug Sales Market Share by Region in 2019
Figure 59. Asia Pacific Bio-protein Drug Revenue Market Share by Region in 2019
Figure 60. China Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Bio-protein Drug Market Share by Type in 2019
Figure 83. Asia Pacific Bio-protein Drug Market Share by Application in 2019
Figure 84. Latin America Bio-protein Drug Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Bio-protein Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Bio-protein Drug Sales Market Share by Country in 2019
Figure 87. Latin America Bio-protein Drug Revenue Market Share by Country in 2019
Figure 88. Mexico Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Bio-protein Drug Market Share by Type in 2019
Figure 95. Latin America Bio-protein Drug Market Share by Application in 2019
Figure 96. Middle East and Africa Bio-protein Drug Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Bio-protein Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Bio-protein Drug Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Bio-protein Drug Revenue Market Share by Country in 2019
Figure 100. Turkey Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Bio-protein Drug Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Bio-protein Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Bio-protein Drug Market Share by Type in 2019
Figure 107. Middle East and Africa Bio-protein Drug Market Share by Application in 2019
Figure 108. North America Bio-protein Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Bio-protein Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Bio-protein Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Bio-protein Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Bio-protein Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Bio-protein Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Bio-protein Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Bio-protein Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Bio-protein Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Bio-protein Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
治療用組換え抗体・タンパク質の世界市場（～2026年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…- がんワクチン薬剤用パイプラインの世界市場（～2026年） Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. Germany, the U.S. and Japan represent the largest markets for cancer vaccine manufacturers. Market Analysis and Insights: Global Cancer Vaccines Drug Pipeline Mark…
- PEG化タンパク質治療薬の世界市場（～2026年） PEGylation is the process of covalent and non-covalent attachment of polyethylene glycol polymer chains to molecules, such as a drug, therapeutic protein, or vesicle. PEGylated protein therapeutics is estimated to show significant market growth during the forecast period, majorly due to the, growth …
- タンパク質発現の世界市場（～2026年） Market Analysis and Insights: Global Protein Expression Market The global Protein Expression market size is projected to reach US$ 1722.5 million by 2026, from US$ 1609.1 million in 2020, at a CAGR of 6.5%% during 2021-2026. Global Protein Expression Scope and Market Size Protein Expression market i…
- 副鼻腔治療薬の世界市場（～2026年） Market Analysis and Insights: Global Sinus Therapeutic Drug Market The global Sinus Therapeutic Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…